Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|April 12, 2019
The effects of erythropoiesis-stimulating agents on the management of chemotherapy-induced anemia and tumor growth in diffuse large B-cell lymphoma patientsLee Chun Park, Yeon-Joo Song, Da Jung Kim, et al.
Environmental Research|March 12, 2026
Volatile organic compounds exposure and all health outcomes: an umbrella review and evidence mapJungmin Lee, Yeona Jo, Jinyoung Jeong, et al.
Scientific Reports|February 13, 2023
Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in KoreaDa Jung Kim, Seri Jeong, Seom Gim Kong, et al.
Plos One|July 30, 2020
The risk factors associated with treatment-related mortality in 16,073 kidney transplantation-A nationwide cohort studyHyunji Choi, Woonhyoung Lee, Ho Sup Lee, et al.
Journal of Hazardous Materials|January 21, 2026
Heavy metal exposure and all health outcomes: An umbrella review of meta-analysesHogeon Lee, Yeona Jo, Minwoo Jung, et al.
Oncotarget|November 8, 2017
Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS Working PartyDa Jung Kim, Ho Sup Lee, Joon-Ho Moon, et al.
Cancer Research and Treatment|March 7, 2024
Nation-Wide Retrospective Analysis of Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma: A Study from Korean Multiple Myeloma Working Party (KMM1913)Ho-Jin Shin, Do-Young Kim, Kihyun Kim, et al.
Scientific Reports|August 10, 2020
Genetic heterogeneity and prognostic impact of recurrent ANK2 and TP53 mutations in mantle cell lymphoma: a multi-centre cohort studySeri Jeong, Yu Jin Park, Woobin Yun, et al.
Blood Cancer Journal|December 2, 2021
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CTHee Jeong Cho, Sung-Hoon Jung, Jae-Cheol Jo, et al.
Annals of Hematology|May 22, 2026
Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemiaSeok Lee, Hyeoung-Joon Kim, June-Won Cheong, et al.
Pageof 7